Healthcare provider profile · identity verified

Timothy J Nussbaum, MD

Family Practice · GREENWOOD, IN · NPI 1770565145

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1051	276
Omeprazole	Omeprazole	429	122
Levothyroxine Sodium	Levothyroxine Sodium	419	87
Amlodipine Besylate	Amlodipine Besylate	360	101
Metoprolol Succinate	Metoprolol Succinate	318	84
Lisinopril	Lisinopril	302	86
Losartan Potassium	Losartan Potassium	251	69
Alendronate Sodium	Alendronate Sodium	225	68
Alprazolam	Alprazolam	213	45
Albuterol Sulfate Hfa	Albuterol Sulfate	208	86
Gabapentin	Gabapentin	174	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	40
Famotidine	Famotidine	160	47
Duloxetine Hcl	Duloxetine Hcl	148	35
Tramadol Hcl	Tramadol Hcl	148	31
Pantoprazole Sodium	Pantoprazole Sodium	145	44
Tamsulosin Hcl	Tamsulosin Hcl	139	44
Hydrochlorothiazide	Hydrochlorothiazide	133	37
Fluoxetine Hcl	Fluoxetine Hcl	128	37
Allopurinol	Allopurinol	125	35
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	118	30
Montelukast Sodium	Montelukast Sodium	114	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	107	47
Zolpidem Tartrate	Zolpidem Tartrate	99	22
Pravastatin Sodium	Pravastatin Sodium	90	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	25
Carvedilol	Carvedilol	86	24
Meloxicam	Meloxicam	85	33
Prednisone	Prednisone	82	72
Diclofenac Sodium	Diclofenac Sodium	77	49
Metformin Hcl	Metformin Hcl	77	22
Doxycycline Hyclate	Doxycycline Hyclate	76	66
Lorazepam	Lorazepam	75	suppressed
Sertraline Hcl	Sertraline Hcl	74	19
Potassium Chloride	Potassium Chloride	72	24
Venlafaxine Hcl Er	Venlafaxine Hcl	69	18
Metoprolol Tartrate	Metoprolol Tartrate	66	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	13
Cephalexin	Cephalexin	63	49
Donepezil Hcl	Donepezil Hcl	61	17
Furosemide	Furosemide	61	16
Clopidogrel	Clopidogrel Bisulfate	60	15
Trazodone Hcl	Trazodone Hcl	59	18
Atenolol	Atenolol	57	14
Glimepiride	Glimepiride	57	15
Paroxetine Hcl	Paroxetine Hcl	56	16
Rosuvastatin Calcium	Rosuvastatin Calcium	56	17
Ropinirole Hcl	Ropinirole Hcl	54	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	53	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	15
Metformin Hcl Er	Metformin Hcl	51	15
Simvastatin	Simvastatin	50	12
Azithromycin	Azithromycin	49	43
Doxazosin Mesylate	Doxazosin Mesylate	44	11
Escitalopram Oxalate	Escitalopram Oxalate	43	15
Ezetimibe	Ezetimibe	37	11
Pregabalin	Pregabalin	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	12
Spironolactone	Spironolactone	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Finasteride	Finasteride	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Hydrocortisone	Hydrocortisone	25	19
Memantine Hcl	Memantine Hcl	25	suppressed
Temazepam	Temazepam	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Nitroglycerin	Nitroglycerin	21	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Klor-Con M10	Potassium Chloride	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Estradiol	Estradiol	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Fluconazole	Fluconazole	16	12
Gemfibrozil	Gemfibrozil	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Glipizide	Glipizide	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	12
Myrbetriq	Mirabegron	15	suppressed
Naproxen	Naproxen	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	14	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Progesterone	Progesterone, Micronized	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Xanax	Alprazolam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Indapamide	Indapamide	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error